{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:17Z","timestamp":1787020937884,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Key Research and Development Program of Jiangxi province","award":["20192BBGL70049"],"award-info":[{"award-number":["20192BBGL70049"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Propranolol is a first-line clinical drug for infantile haemangiomas (IH) therapy. Nevertheless, resistance to propranolol is observed in some patients with IH. Circular RNAs (circRNAs) has been increasingly reported to act as a pivotal regulator in tumor progression. However, the underlying mechanism of circRNAs in IH remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Quantitative real-time polymerase chain reaction\u00a0was performed to detect Circ_0000915, miR-890 and RNF187 expression. Protein levels were determined using western blot. CCK-8 assay was used to measure cell proliferation. Caspase-3 activity assay and flow cytometry were conducted to determine cell apoptosis. Luciferase reporter assay was carried out to assess the interaction between miR-890 and Circ_0000915 or RNF187. Chromatin immunoprecipitation assay was performed to detect the interaction between STAT3 and Circ_0000915 promoter. Biotin pull-down assay was used to detect the direct interaction between miR-890 and Circ_0000915. In vivo experiments were performed to measure tumor formation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we discovered depletion of Circ_0000915 increased propranolol sensitivity of haemangioma derived stem cells (HemSCs) both in vitro and in vivo, whereas forced expression of Circ_0000915 exhibited opposite effects. Mechanistically, Circ_0000915, transcriptionally induced by IL-6\/STAT3 pathway, competed with RNF187 for the biding site in miR-890, led to upregulation of RNF187 by acting as a miR-890\u00a0\u201csponge\u201d. Furthermore, silence of miR-890 reversed increased propranolol sensitivity of HemSCs due to Circ_0000915 ablation. Moreover, increased Circ_0000915 and RNF187 levels were observed in IH tissues and positively associated with propranolol resistance, miR-890 exhibited an inverse expression pattern.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We thereby uncover the activation of IL-6\/STAT3\/Circ_0000915\/miR-890\/RNF187 axis in propranolol resistance of IH, and provide therapeutic implications for patients of IH with propranolol resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40246-022-00416-w","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T07:19:17Z","timestamp":1664263157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Circular RNA hsa_circ_0000915 promotes propranolol resistance of hemangioma stem cells in infantile haemangiomas"],"prefix":"10.1186","volume":"16","author":[{"given":"Hongrang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"issue":"4","key":"416_CR1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/bjd.12804","volume":"170","author":"A Munden","year":"2014","unstructured":"Munden A, et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014;170(4):907\u201313.","journal-title":"Br J Dermatol"},{"issue":"11","key":"416_CR2","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1468-3083.2011.04102.x","volume":"25","author":"C Leaute-Labreze","year":"2011","unstructured":"Leaute-Labreze C, Prey S, Ezzedine K. Infantile haemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol. 2011;25(11):1245\u201353.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"416_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/PRS.0b013e31825dc129","volume":"130","author":"RA Couto","year":"2012","unstructured":"Couto RA, et al. Infantile hemangioma: clinical assessment of the involuting phase and implications for management. Plast Reconstr Surg. 2012;130(3):619\u201324.","journal-title":"Plast Reconstr Surg"},{"issue":"24","key":"416_CR4","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C Leaute-Labreze","year":"2008","unstructured":"Leaute-Labreze C, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649\u201351.","journal-title":"N Engl J Med"},{"issue":"4","key":"416_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.bjps.2010.07.009","volume":"64","author":"WJM Holmes","year":"2011","unstructured":"Holmes WJM, et al. Propranolol as first-line treatment for rapidly proliferating Infantile Haemangiomas. J Plast Reconstr Aesthet Surg. 2011;64(4):445\u201351.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"416_CR6","doi-asserted-by":"crossref","unstructured":"Bleiker T. Propranolol-resistant infantile haemangiomas. Br J Dermatol. 2013;169(1).","DOI":"10.1111\/bjd.12448"},{"issue":"7","key":"416_CR7","first-page":"2592","volume":"118","author":"ZA Khan","year":"2008","unstructured":"Khan ZA, et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Investig. 2008;118(7):2592\u20139.","journal-title":"J Clin Investig"},{"issue":"4","key":"416_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10456-010-9189-6","volume":"13","author":"S Greenberger","year":"2010","unstructured":"Greenberger S, et al. Targeting NF-kappa B in infantile hemangioma-derived stem cells reduces VEGF-A expression. Angiogenesis. 2010;13(4):327\u201335.","journal-title":"Angiogenesis"},{"issue":"11","key":"416_CR9","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa0903036","volume":"362","author":"S Greenberger","year":"2010","unstructured":"Greenberger S, et al. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med. 2010;362(11):1005\u201313.","journal-title":"N Engl J Med"},{"issue":"8","key":"416_CR10","doi-asserted-by":"publisher","first-page":"13494","DOI":"10.3390\/ijms150813494","volume":"15","author":"E Smolle","year":"2014","unstructured":"Smolle E, Haybaeck J. Non-coding RNAs and lipid metabolism. Int J Mol Sci. 2014;15(8):13494\u2013513.","journal-title":"Int J Mol Sci"},{"issue":"7441","key":"416_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333\u20138.","journal-title":"Nature"},{"issue":"3","key":"416_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/wrna.1213","volume":"5","author":"RO Bak","year":"2014","unstructured":"Bak RO, Mikkelsen JG. miRNA sponges: soaking up miRNAs for regulation of gene expression. Wiley Interdiscip Rev RNA. 2014;5(3):317\u201333.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"416_CR13","doi-asserted-by":"crossref","unstructured":"Zheng QP, et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016;7.","DOI":"10.1038\/ncomms11215"},{"issue":"3","key":"416_CR14","first-page":"298","volume":"113","author":"WLW Tan","year":"2017","unstructured":"Tan WLW, et al. A landscape of circular RNA expression in the human heart. Cardiovasc Res. 2017;113(3):298\u2013309.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"416_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/hepr.12871","volume":"47","author":"T Yao","year":"2017","unstructured":"Yao T, et al. Circular RNAs: Biogenesis, properties, roles, and their relationships with liver diseases. Hepatol Res. 2017;47(6):497\u2013504.","journal-title":"Hepatol Res"},{"key":"416_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.gde.2017.11.007","volume":"48","author":"IL Patop","year":"2018","unstructured":"Patop IL, Kadener S. circRNAs in Cancer. Curr Opin Genet Dev. 2018;48:121\u20137.","journal-title":"Curr Opin Genet Dev"},{"key":"416_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2018.12.002","volume":"58","author":"E Arnaiz","year":"2019","unstructured":"Arnaiz E, et al. CircRNAs and cancer: biomarkers and master regulators. Semin Cancer Biol. 2019;58:90\u20139.","journal-title":"Semin Cancer Biol"},{"key":"416_CR18","doi-asserted-by":"crossref","unstructured":"Xu JZ, et al. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p\/SOCS3 axis. Cell Death Dis. 2019;10.","DOI":"10.1038\/s41419-019-1382-y"},{"key":"416_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2019.11.038","volume":"471","author":"J Lu","year":"2020","unstructured":"Lu J, et al. Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis. Cancer Lett. 2020;471:38\u201348.","journal-title":"Cancer Lett"},{"issue":"22","key":"416_CR20","doi-asserted-by":"publisher","first-page":"9982","DOI":"10.18632\/aging.102356","volume":"11","author":"Q Tang","year":"2019","unstructured":"Tang Q, et al. Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1. Aging (Albany NY). 2019;11(22):9982\u201399.","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"416_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187581","volume":"12","author":"C Fu","year":"2017","unstructured":"Fu C, et al. Circular RNA profile of infantile hemangioma by microarray analysis. PLoS ONE. 2017;12(11): e0187581.","journal-title":"PLoS ONE"},{"issue":"7","key":"416_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23258","volume":"34","author":"X Yuan","year":"2020","unstructured":"Yuan X, et al. CircAP2A2 acts as a ceRNA to participate in infantile hemangiomas progression by sponging miR-382-5p via regulating the expression of VEGFA. J Clin Lab Anal. 2020;34(7): e23258.","journal-title":"J Clin Lab Anal"},{"issue":"21","key":"416_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010882","volume":"97","author":"J Li","year":"2018","unstructured":"Li J, et al. Expression profile of circular RNAs in infantile hemangioma detected by RNA-Seq. Medicine (Baltimore). 2018;97(21): e10882.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"416_CR24","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1111\/cas.13332","volume":"108","author":"H Kitamura","year":"2017","unstructured":"Kitamura H, et al. Interleukin-6\/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy. Cancer Sci. 2017;108(10):1947\u201352.","journal-title":"Cancer Sci"},{"key":"416_CR25","doi-asserted-by":"crossref","unstructured":"Tengesdal, I.W., et al. Tumor NLRP3-derived IL-1 beta drives the IL-6\/STAT3 axis resulting in sustained MDSC-mediated immunosuppression. Front Immunol. 2021;12.","DOI":"10.3389\/fimmu.2021.661323"},{"issue":"5","key":"416_CR26","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.7150\/thno.53169","volume":"11","author":"GF Lu","year":"2021","unstructured":"Lu GF, et al. NEK9, a novel effector of IL-6\/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation. Theranostics. 2021;11(5):2460\u201374.","journal-title":"Theranostics"},{"issue":"4","key":"416_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/carcin\/bgv017","volume":"36","author":"H Liu","year":"2015","unstructured":"Liu H, et al. Aberrantly expressed Fra-1 by IL-6\/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition. Carcinogenesis. 2015;36(4):459\u201368.","journal-title":"Carcinogenesis"},{"key":"416_CR28","doi-asserted-by":"crossref","unstructured":"Wu J., et al. Long noncoding RNA lncTCF7, induced by IL-6\/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. J Exp Clin Cancer Res. 2015;34.","DOI":"10.1186\/s13046-015-0229-3"},{"issue":"11","key":"416_CR29","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1182\/blood-2006-12-062471","volume":"109","author":"JM Melero-Martin","year":"2007","unstructured":"Melero-Martin JM, et al. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood. 2007;109(11):4761\u20138.","journal-title":"Blood"},{"issue":"1","key":"416_CR30","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1038\/s41467-019-11162-4","volume":"10","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, et al. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat Commun. 2019;10(1):3200.","journal-title":"Nat Commun"},{"key":"416_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116946","volume":"239","author":"MM Li","year":"2019","unstructured":"Li MM, et al. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3\/NF-kappaB pathway. Life Sci. 2019;239: 116946.","journal-title":"Life Sci"},{"key":"416_CR32","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.2147\/IJN.S137634","volume":"12","author":"XN Guo","year":"2017","unstructured":"Guo XN, et al. Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth. Int J Nanomed. 2017;12:6923\u201336.","journal-title":"Int J Nanomed"},{"key":"416_CR33","doi-asserted-by":"crossref","unstructured":"Wu HW., et al. Propranolol-loaded mesoporous silica nanoparticles for treatment of infantile hemangiomas. Adv Healthcare Mater. 2019;8(9).","DOI":"10.1002\/adhm.201801261"},{"key":"416_CR34","doi-asserted-by":"crossref","unstructured":"Wang H., et al. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer, 2017;16.","DOI":"10.1186\/s12943-017-0680-1"},{"issue":"7483","key":"416_CR35","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344\u201352.","journal-title":"Nature"},{"key":"416_CR36","doi-asserted-by":"crossref","unstructured":"Wang YA., et al. The influence of circular RNAs on autophagy and disease progression. Autophagy; 2021.","DOI":"10.1080\/15548627.2021.1917131"},{"issue":"3","key":"416_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.12788\/j.sder.2016.050","volume":"35","author":"CE Cheng","year":"2016","unstructured":"Cheng CE, Friedlander SF. Infantile hemangiomas, complications and treatments. Semin Cutan Med Surg. 2016;35(3):108\u201316.","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"416_CR38","doi-asserted-by":"publisher","first-page":"E128","DOI":"10.1097\/SCS.0000000000004152","volume":"29","author":"L Chang","year":"2018","unstructured":"Chang L, et al. Intralesional bleomycin injection for propranolol-resistant hemangiomas. J Craniofacial Surg. 2018;29(2):E128\u201330.","journal-title":"J Craniofacial Surg"},{"issue":"3","key":"416_CR39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4161\/derm.26739","volume":"5","author":"SM Todorovich","year":"2013","unstructured":"Todorovich SM, Khan ZA. Elevated T-box 2 in infantile hemangioma stem cells maintains an adipogenic differentiation-competent state. Dermatoendocrinol. 2013;5(3):352\u20137.","journal-title":"Dermatoendocrinol"},{"issue":"1","key":"416_CR40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3760\/cma.j.issn.0366-6999.20121141","volume":"126","author":"HM Mai","year":"2013","unstructured":"Mai HM, et al. CD133 selected stem cells from proliferating infantile hemangioma and establishment of an in vivo mice model of hemangioma. Chin Med J (Engl). 2013;126(1):88\u201394.","journal-title":"Chin Med J (Engl)"},{"key":"416_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fsurg.2018.00031","volume":"5","author":"L Sulzberger","year":"2018","unstructured":"Sulzberger L, et al. Phosphorylated forms of STAT1, STAT3 and STAT5 are expressed in proliferating but not involuted infantile hemangioma. Front Surg. 2018;5:31.","journal-title":"Front Surg"},{"key":"416_CR42","doi-asserted-by":"crossref","unstructured":"Tsoi H., et al. Targeting the IL-6\/STAT3 signalling cascade to reverse tamoxifen resistance in estrogen receptor positive breast cancer. Cancers, 2021;13(7).","DOI":"10.3390\/cancers13071511"},{"key":"416_CR43","doi-asserted-by":"crossref","unstructured":"Shriki A., et al. Multiple roles of IL-6 in hepatic injury, steatosis, and senescence aggregate to suppress tumorigenesis. Cancer Res;2021.","DOI":"10.1158\/0008-5472.CAN-21-0321"},{"issue":"10","key":"416_CR44","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jmedgenet-2015-103334","volume":"52","author":"XL Qi","year":"2015","unstructured":"Qi XL, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710\u20138.","journal-title":"J Med Genet"},{"issue":"4","key":"416_CR45","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1002\/jcp.29291","volume":"235","author":"X Ma","year":"2020","unstructured":"Ma X, et al. circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer. J Cell Physiol. 2020;235(4):3973\u201383.","journal-title":"J Cell Physiol"},{"issue":"5","key":"416_CR46","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4149\/neo_2019_190107N25","volume":"66","author":"L Liu","year":"2019","unstructured":"Liu L, et al. Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer. Neoplasma. 2019;66(5):736\u201345.","journal-title":"Neoplasma"},{"issue":"1","key":"416_CR47","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12885-019-5796-9","volume":"19","author":"C Wang","year":"2019","unstructured":"Wang C, et al. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147. BMC Cancer. 2019;19(1):577.","journal-title":"BMC Cancer"},{"issue":"16","key":"416_CR48","first-page":"8429","volume":"24","author":"XQ Xia","year":"2020","unstructured":"Xia XQ, et al. LINC00662 promotes cell proliferation, migration and invasion of melanoma by sponging miR-890 to upregulate ELK3. Eur Rev Med Pharmacol Sci. 2020;24(16):8429\u201338.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"416_CR49","doi-asserted-by":"publisher","first-page":"14161","DOI":"10.1002\/jcp.28111","volume":"234","author":"Z Fu","year":"2019","unstructured":"Fu Z, et al. Overexpression of RNF187 induces cell EMT and apoptosis resistance in NSCLC. J Cell Physiol. 2019;234(8):14161\u20139.","journal-title":"J Cell Physiol"},{"issue":"6","key":"416_CR50","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.7150\/jca.33488","volume":"11","author":"WB Wan","year":"2020","unstructured":"Wan WB, et al. High level of RNF187 contributes to the progression and drug resistance of osteosarcoma. J Cancer. 2020;11(6):1351\u20138.","journal-title":"J Cancer"},{"issue":"1","key":"416_CR51","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s13046-019-1382-x","volume":"38","author":"L Zhang","year":"2019","unstructured":"Zhang L, et al. An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38(1):384.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-022-00416-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-022-00416-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-022-00416-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T15:15:47Z","timestamp":1728054947000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-022-00416-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1186\/s40246-022-00416-w","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were approved by the Ethics Committee of the First Affiliated Hospital of Anhui Medical University and in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. We state the material is original research, has not been previously published and is not currently being considered for publication elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"43"}}